1. Home
  2. YXT vs PMVP Comparison

YXT vs PMVP Comparison

Compare YXT & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YXT
  • PMVP
  • Stock Information
  • Founded
  • YXT 2011
  • PMVP 2013
  • Country
  • YXT China
  • PMVP United States
  • Employees
  • YXT N/A
  • PMVP N/A
  • Industry
  • YXT
  • PMVP Medicinal Chemicals and Botanical Products
  • Sector
  • YXT
  • PMVP Health Care
  • Exchange
  • YXT NYSE
  • PMVP Nasdaq
  • Market Cap
  • YXT 52.8M
  • PMVP 55.1M
  • IPO Year
  • YXT 2024
  • PMVP 2020
  • Fundamental
  • Price
  • YXT $0.90
  • PMVP $1.25
  • Analyst Decision
  • YXT
  • PMVP Strong Buy
  • Analyst Count
  • YXT 0
  • PMVP 1
  • Target Price
  • YXT N/A
  • PMVP $5.00
  • AVG Volume (30 Days)
  • YXT 8.9K
  • PMVP 230.0K
  • Earning Date
  • YXT 08-21-2025
  • PMVP 08-07-2025
  • Dividend Yield
  • YXT N/A
  • PMVP N/A
  • EPS Growth
  • YXT N/A
  • PMVP N/A
  • EPS
  • YXT N/A
  • PMVP N/A
  • Revenue
  • YXT $45,374,087.00
  • PMVP N/A
  • Revenue This Year
  • YXT N/A
  • PMVP N/A
  • Revenue Next Year
  • YXT N/A
  • PMVP N/A
  • P/E Ratio
  • YXT $1.42
  • PMVP N/A
  • Revenue Growth
  • YXT N/A
  • PMVP N/A
  • 52 Week Low
  • YXT $0.47
  • PMVP $0.81
  • 52 Week High
  • YXT $11.00
  • PMVP $1.82
  • Technical
  • Relative Strength Index (RSI)
  • YXT N/A
  • PMVP 64.21
  • Support Level
  • YXT N/A
  • PMVP $0.96
  • Resistance Level
  • YXT N/A
  • PMVP $1.36
  • Average True Range (ATR)
  • YXT 0.00
  • PMVP 0.09
  • MACD
  • YXT 0.00
  • PMVP 0.01
  • Stochastic Oscillator
  • YXT 0.00
  • PMVP 72.22

About YXT YXT.COM GROUP HOLDING LIMITED SPON ADS EA REP 3 CL A SHS

Yxt.Com Group Holding Ltd operates as a technology company. The company has created a SaaS model that integrates software and content, assisting customers in the digital transformation of corporate learning. The company operates in the People's Republic of China.

About PMVP PMV Pharmaceuticals Inc.

PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.

Share on Social Networks: